-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
background:
Background: Background:Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD), especially those in which diabetes is the underlying cause of CKD
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD), especially those in which diabetes is the underlying cause of CKD
Many low-molecular-weight organic metabolites accumulate in CKD
SDMA and ADMA arise from the metabolism of proteins containing methylated arginine residues
SDMA and ADMA arise from the metabolism of proteins containing methylated arginine residues
Purpose: Purpose:
Although there is some precedent for ADMA, SDMA, and TMAO as biomarkers for CVD in DKD, validation for clinical application is insufficient
Although there is some precedent for ADMA, SDMA, and TMAO as biomarkers for CVD in DKD, validation for clinical application is insufficient
method: method:
Randomized 555 diabetic patients with EGFR<60ml/min/1.
Randomized 555 diabetic patients with EGFR<60ml/min/1.
Result: Result:
The mean baseline EGFR was 44ml/min/1.
The mean baseline EGFR was 44ml/min/1.
Limitations: Single cohort, limited to diabetic patients with EGFR <60, potential residual confounding of GFR, no dietary information
Table 1.
Table 2.
Table 2.
Table 3.
Table 3.
Association of Baseline Urine/Plasma (U/P) ADMA, SDMA, and TMAO with Cardiovascular Mortality
Table 4.
Association of Baseline Urine/Plasma (U/P) ADMA, SDMA, and TMAO with All-Cause Mortality
Association of Baseline Urine/Plasma (U/P) ADMA, SDMA, and TMAO with All-Cause Mortality
Table 6
.
Association of baseline plasma ADMA, SDMA and TMAO with KFRT
.
Association of baseline plasma ADMA, SDMA and TMAO with KFRT
in conclusion:
in conclusion:Higher plasma concentrations and lower uremic solute U/P ratios were independently associated with CV and all-cause mortality in DKD
.
The association of U/P ratios with mortality suggests a link between renal uremic solute clearance and the onset of cardiovascular disease
.
.
The association of U/P ratios with mortality suggests a link between renal uremic solute clearance and the onset of cardiovascular disease
.
Higher plasma concentrations and lower uremic solute U/P ratios were independently associated with CV and all-cause mortality in DKD
.
The association of U/P ratios with mortality suggests a link between renal uremic solute clearance and the onset of cardiovascular disease
.
Original source: Sapa H, Gutiérrez OM, Shlipak MG, et al.
Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
Am J Kidney Dis 2022 Mar 26
Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
Am J Kidney Dis 2022 Mar 26 Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
Leave a message here